RxCelerate
Jennifer Hillman is an experienced scientific professional with a strong background in biochemistry and a focus on assay development. Currently serving as In vitro Team Leader at RXCELERATE LIMITED since February 2022, Jennifer has previously held significant roles including Senior Assay Scientist at Avacta from January 2017 to February 2022, and Senior Scientist and Research Scientist at BioFocus from August 2010 to January 2017. Prior positions include Research Scientist at Evotec and Summit plc, as well as Research Assistant at Cambridge Antibody Technology. Jennifer earned a BSc in Biochemistry with Study in Industry from the University of Bristol in 2006.
This person is not in any teams
RxCelerate
1 followers
RxCelerate Limited is a leading outsourced drug development company based in Cambridge (U.K) delivering complete preclinical programmes to our clients. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. Connect with us to be part of our exciting journey!